Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer

Jiaojiao Zheng; Chen Li; Weihui Lu; Cong Wang; Zhilong Ai

doi:10.18632/oncotarget.9201

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer

Jiaojiao Zheng, Chen Li, Weihui Lu, Cong Wang and Zhilong Ai _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:34918-34929. https://doi.org/10.18632/oncotarget.9201

Metrics: PDF 1578 views | HTML 3079 views | ?

Abstract

Jiaojiao Zheng1,*, Chen Li1,*, Weihui Lu2,*, Cong Wang1,*, Zhilong Ai1

1Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, P.R. China

2Department of General Surgery, Zhongshan Hospital (Qingpu Branch), Fudan University, Shanghai 201700, P.R. China

*These authors contributed equally to this work

Correspondence to:

Zhilong Ai, email: [email protected]

Keywords: thyroid stimulating hormone, thyroid cancer, TNM staging, lymph node metastasis, meta-analysis

Received: January 11, 2016 Accepted: April 16, 2016 Published: May 06, 2016

ABSTRACT

Thyroid stimulating hormone (TSH) is the major growth factor for thyrocytes, but the pathogenic role of serum TSH in thyroid cancer (TC) is unknown. The association between TSH level and the development of thyroid cancer has been widely evaluated recently. However, the results remain conflicting. To develop an understanding of the relationship between TSH exposure and thyroid cancer, a meta-analysis of 56 studies involving 20227 thyroid cancer cases and 50003 controls with benign thyroid nodule was performed. Overall, significantly increased TSH level was observed in thyroid cancer patients compared with controls (RoM: 1.44, 95% CI: 1.32–1.56, P < 10^–5). The pooled analyses also revealed that higher serum TSH level were significantly associated with the size of TC nodule and malignancy as well as lymph node metastasis. Furthermore, significantly increased THS levels were observed preferentially for papillary thyroid cancer when stratified by histological type of tumors. However, the diagnostic value of TSH level for TC might be limited. These results suggest that higher serum TSH concentration is associated with an increased risk of thyroid cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 9201

Publication Alerts

Research Papers:

Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer

Abstract